SELECTIVE INHIBITION OF THROMBOXANE BIOSYNTHESIS IN HUMAN BLOOD MONONUCLEAR CELLS AND THE EFFECTS ON MITOGEN‐STIMULATED LYMPHOCYTE PROLIFERATION
暂无分享,去创建一个
[1] H. Tyler,et al. ADMINISTRATION TO MAN OF UK-37,248-01, A SELECTIVE INHIBITOR OF THROMBOXANE SYNTHETASE , 1981, The Lancet.
[2] D. Gordon,et al. Is prostacyclin in the major pro-inflammatory prostanoid in joint fluid? , 1980, Life sciences.
[3] M. Goldyne,et al. In vitro synthesis of prostaglandins and related lipids by populations of human peripheral blood mononuclear cells. , 1980, Prostaglandins.
[4] Miller Jj. The imidazoles as immunosuppressive agents. , 1980 .
[5] E. Benveniste,et al. Functional properties of human T cells bearing Fc receptors for IgA. I. Mitogen responsiveness, mixed lymphocyte culture reactivity, and helper activity for B cell immunoglobulin production. , 1980, Journal of immunology.
[6] F. Hirata,et al. Phospholipid methylation: a biochemical signal modulating lymphocyte mitogenesis. , 1980, Proceedings of the National Academy of Sciences of the United States of America.
[7] J. Miller. The imidazoles as immunosuppressive agents. , 1980, Transplantation proceedings.
[8] R. Williams,et al. Cyclic adenosine monophosphate response to prostaglandin E2 on subpopulations of human lymphocytes , 1979, The Journal of experimental medicine.
[9] J. Westwick,et al. EFFECTS OF PROSTAGLANDINS E2 AND I2 ON HUMAN LYMPHOCYTE TRANSFORMATION IN THE PRESENCE AND ABSENCE OF INHIBITORS OF PROSTAGLANDIN BIOSYNTHESIS , 1979, British journal of pharmacology.
[10] E. F. Smith,et al. Synthesis and biological properties of pinane-thromboxane A2, a selective inhibitor of coronary artery constriction, platelet aggregation, and thromboxane formation. , 1979, Proceedings of the National Academy of Sciences of the United States of America.
[11] M. A. Bray,et al. Prostaglandin and thromboxane production by human and guinea-pig macrophages and leucocytes. , 1979, Prostaglandins.
[12] M. C. Johnson,et al. Effect of inhibitors of arachidonic acid metabolism on mitogenesis in human lymphocytes: possible role of thromboxanes and products of the lipoxygenase pathway. , 1979, Journal of immunology.
[13] T. Sloan,et al. Connective tissue activation. XIV. Composition and actions of a human platelet autacoid mediator. , 1979, Arthritis and rheumatism.
[14] R. Messner,et al. Prostaglandin suppression of mitogen-stimulated lymphocytes in vitro. Changes with mitogen dose and preincubation. , 1978, The Journal of clinical investigation.
[15] M. A. Bray,et al. PROSTAGLANDIN PRODUCTION BY MACROPHAGES AND THE EFFECT OF ANTI‐INFLAMMATORY DRUGS , 1978, British journal of pharmacology.
[16] J. Ferrendelli,et al. Thromboxane synthetase inhibitors as pharmacological tools: differential biochemical and biological effects on platelet suspensions. , 1977, Prostaglandins.
[17] Ritchie Jc,et al. Connective tissue activation. XI. Stimulation of glycosaminoglycan and DNA formation by a platelet factor. , 1977 .
[18] J. Vane,et al. Imidazole: a selective inhibitor of thromboxane synthetase. , 1977, Prostaglandins.
[19] J. Ritchie,et al. Connective tissue activation. XI. Stimulation of glycosaminoglycan and DNA formation by a platelet factor. , 1977, Arthritis and rheumatism.
[20] M. Ferrarini,et al. Subpopulations of human T cells identified by receptors for immunoglobulins and mitogen responsiveness. , 1976, Journal of immunology.
[21] R. Wyburn-Mason. CLOTRIMAZOLE AND RHEUMATOID ARTHRITIS , 1976, The Lancet.
[22] I. Otterness,et al. CLOTRIMAZOLE AND RHEUMATOID ARTHRITIS , 1976, The Lancet.
[23] J. Hadden,et al. Effects of levamisole and imidazole on lymphocyte proliferation and cyclic nucleotide levels. , 1975, Cellular immunology.